Matthew Klinker
CBER, FDA
Matthew Klinker, PhD is an immunologist and cell therapy product reviewer in the Division of Cellular and Gene Therapies in the US Food & Drug Administration. He has experience reviewing products derived from a wide variety of cell types throughout the product development lifecycle, from pre-IND submissions through biologics licensing applications.